U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 8 of 8 results

Status:
Other

Class (Stereo):
CHEMICAL (ACHIRAL)

Conditions:

Lithium diisopropylamide (LDA) is a prominent reagent used in organic synthesis. It is strong, low-nucleophilic base for e.g. enolisations. Corrosive to the eyes (may cause blindness), skin, mucous membranes and upper respiratory tract. Inhalation of...
Status:
Possibly Marketed Outside US
First approved in 2000

Class (Stereo):
CHEMICAL (ACHIRAL)



Diisopropylamine (DIPA) is a secondary amine, which is used as a chemical intermediate, and catalyst for the synthesis of pesticides and pharmaceuticals. DIPA is primarily used as a precursor for the herbicides dilate and triallate, as well as certai...
Status:
Possibly Marketed Outside US
First approved in 1985

Class (Stereo):
CHEMICAL (ACHIRAL)

Conditions:

Glutaraldehyde is marketed by The Dow Chemical Company under several trade names in a wide range of applications from leather tanning, photography, paper, water treatment, and high level disinfection of medical instrumentation to animal husbandry. Bi...
mixture
Status:
US Approved OTC
First marketed in 1921

Class:
MIXTURE



Bacitracin is a polypeptide antibiotic produced by Bacillus subtilis and Bacillus licheniformis. Bacitracin in combination with neomycin and polymyxin B is indicated for the treatment of many bacterial diseases. The antibacterial properties of bacitr...
Status:
US Approved OTC
First marketed in 1921

Class (Stereo):
CHEMICAL (ACHIRAL)



Bacitracin is a polypeptide antibiotic produced by Bacillus subtilis and Bacillus licheniformis. Bacitracin in combination with neomycin and polymyxin B is indicated for the treatment of many bacterial diseases. The antibacterial properties of bacitr...
mixture
Status:
US Approved OTC
First marketed in 1921

Class:
MIXTURE



Bacitracin is a polypeptide antibiotic produced by Bacillus subtilis and Bacillus licheniformis. Bacitracin in combination with neomycin and polymyxin B is indicated for the treatment of many bacterial diseases. The antibacterial properties of bacitr...
mixture
Status:
US Approved OTC
First marketed in 1921

Class:
MIXTURE



Bacitracin is a polypeptide antibiotic produced by Bacillus subtilis and Bacillus licheniformis. Bacitracin in combination with neomycin and polymyxin B is indicated for the treatment of many bacterial diseases. The antibacterial properties of bacitr...
mixture
Status:
US Approved OTC
First marketed in 1921

Class:
MIXTURE



Bacitracin is a polypeptide antibiotic produced by Bacillus subtilis and Bacillus licheniformis. Bacitracin in combination with neomycin and polymyxin B is indicated for the treatment of many bacterial diseases. The antibacterial properties of bacitr...